In our study, we found a strong association between PD-L1 and tAXL expression across all NSCLC subgroups, consistent with previous results suggesting that AXL-signaling upregulates PD-L1 in different malignancies (15, 16, 40). This evidence concerns the gene CD274 and non-small cell lung carcinoma.